Stéphanie Combes;Dorte Renneberg;Francis Hubler;Katharina Reichenbaecher;Jacques-Alexis Funel;Stefan Abele;Markus Von Raumer;Kurt Hilpert
发明人:
Stefan Abele,Stéphanie Combes,Jacques-Alexis Funel,Kurt Hilpert,Francis Hubler,Katharina Reichenbaecher,Dorte Renneberg,Markus Von Raumer
申请号：
US13125443
公开号：
US08492555B2
申请日:
2009.10.21
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The invention relates to crystalline salts of isobutyric acid (1R*,2R*,4R*)-2-(2-{[3-(4,7 -dimethoxy-1H-benzoimidazol-2-yl)-propyl]-methyl-amino}-ethyl)-5-phenyl-bicyclo[2.2.2]oct-5-en-2-yl ester, processes for the preparation thereof, pharmaceutical compositions containing said crystalline salts, and their use as medicaments, especially as calcium channel blockers.
